Immunotherapy-mediated modulation of the gut microbiota in multiple sclerosis and associations with diet and clinical response—the effect of dimethyl fumarate therapy
Background: Accumulating evidence supports a role of the microbiota in health and disease, including in multiple sclerosis (MS). How MS drugs affect the microbiota and whether this is part of their mode of action is yet unknown. Objectives: To assess how dimethyl fumarate (DMF) affects the gut micro...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-03-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/17562864241306565 |